RVL Pharmaceuticals PLC expected to post a loss of 21  cents a share - Earnings Preview

RVL Pharmaceuticals

10/05/2022 19:33

* RVL Pharmaceuticals PLC  RVLP.OQ   RVLP.O  is expected
to show a
fall in quarterly revenue when it reports  results on May 12. 
    * The Bridgewater New Jersey-based  company is expected to
report 
a 68.8% decrease in revenue to $7.44 million from $23.88 million
a year ago, according to the mean estimate from 5 analysts,
based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for RVL Pharmaceuticals
PLC
is for a loss of 21 cents per share. For the same quarter last
year, the company reported a loss of 15 cents per share.
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for RVL
Pharmaceuticals PLC is $5​, above​ its last closing price
of $1.33. ​​​
    * Previous quarterly performance (using preferred earnings
measure
in US dollars). ​

 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Dec. 31 2021  -0.25       -0.27      -0.30     Missed  -12.5
 Sep. 30 2021  -0.31       -0.31      -0.28     Beat    11.1
 Jun. 30 2021  -0.14       -0.14      -0.28     Missed  -100​
 Mar. 31 2021  -0.23       -0.23      -0.15     Beat    36.2
 ​​Dec.        -0.28       -0.24      -0.88     Missed  -271.8
 31 2020                                                
 Sep. 30 2020  -0.20       -0.20      -0.14     Beat    30​
 Jun. 30 2020  -0.12       -0.12      -0.22     Missed  -76
 Mar. 31 2020  -0.15       -0.14      -0.05     Beat    65.1
 This summary was machine generated May 10 at 18:32 GMT.  All
figures in US dollars  unless otherwise stated